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 Research on bovine respiratory disease complex (BRDC) has strongly contributed 
to a better understanding of disease at both global and local levels. New agents have 
been identified and their nature has been better known since then, as well as all the 
factors that predispone the development of BRDC. Serious work in a number of 
researches has led to results that have proven significant synergistic interactions 
between viruses and bacteria that lead to the BRDC and complicate the prevention 
and treatment of the diseased cattle. Nowadays, it is necessary to apply the latest 
molecular and other techniques in order to examine in detail all of the specific 
causes, describe them accurately and provide effective prevention. This can 
primarily be accomplished by producing different types of vaccines, which are to be 
improved constantly. Serious progress has been made in researches on 
immunogenic properties and antimicrobial activity of various natural and synthetic 
substances in order to improve the production of more effective vaccines for 
control, as well as the development of a new generation of antibiotics to treat the 
disease. BRDC prevention programs have been successful, in which great 
importance was given to proper vaccinations and herd management practices. 
BRDC is still the most important disease of cattle from an economic point of view, 
since it causes great losses and expenses. 
 
©2013 PVJ. All rights reserved 
Key words:  
Bovine respiratory disease 
complex 
Diagnostic techniques 
Infective agents 
Medications 
Vaccines 
 
To Cite This Article: Kurćubić VS, RD Đoković, ZŽ Ilić, JS Stojković, MP Petrović and V Caro-Petrović, 2014. 
Modern approach to the enigma of bovine respiratory disease complex: a review. Pak Vet J, 34(1): 11-17. 
 
INTRODUCTION 
 
The bovine respiratory disease complex (BRDC) is a 
multi-factorial illness with many variables that in synergy 
cause a disease which usually leads to severe and fatal 
outbreaks of bacterial pneumonia. These facts make it 
difficult to control the BRDC, especially in the categories 
of beef calves before and after weaning (Lazić et al., 
2004). Numerous studies around the world have 
demonstrated a significant role of predisposing factors in 
the development of BRDC (Taylor et al., 2010), included 
environmental (ambient temperature, humidity, 
ventilation, harmful gases and dust) and host factors (age, 
sex, breed, genetics, immune status and concurrent 
disease). Stressful management practices (weaning, 
shipping, changes in diet, high density of animals, 
handling and surgeries) carry a high risk of BRDC 
appearance in cattle herds. The most commonly noticed 
clinical symptoms are: high fever (about 40-41.5ºC), 
decreased appetite, depression, nasal and ocular discharge, 
coughing and different degree of dyspnea (Urban-Chmiel 
and Grooms, 2012). Among a large group of infectious 
agents which participated in the pathogenesis of BRDC, 
the most common viruses involved in BRDC include 
Bovine Viral Diarrhea (BVD), Infectious Bovine 
Rhinotracheitis (IBR), Bovine Respiratory Syncytial 
Virus (BRSV), and Para influenza Type-3 Virus (PI-3V) 
which can cause severe damage to the respiratory tract of 
cattle, creating opportunities for settlement of bacteria in 
the lungs (Pardon et al., 2011). Adherence of bacteria (M. 
haemolytica) to bronchial epithelial cells causes the most 
acute form with progressive inflammation characterized 
by fibrinous bronchopneumonia. Intrauterine infection of 
cattle with non-cytopathogenic (ncp) BVDV in the first 
trimester of gestation is unique, and can play a role in the 
emerging of persistently infected (PI) cattle, chronically 
ill or dying in feedlots (Peterhans et al., 2010). Latest 
research in this field (Raaperi et al., 2012) reveals opinion 
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that BHV-1 was not associated with acute respiratory 
disease in adult dairy cattle, but it caused significant 
changes in reproductive performances. Many authors 
believe that the BRSV has a major role in the onset of 
BRDC in adult dairy cattle. The importance of bovine 
adenovirus, coronavirus, calicivirus, parvovirus, 
herpesvirus type 4, reovirus and rhinovirus is still 
considered episodic (Lazić et al., 2009).  
The most common bacteria found in lungs of calves 
with BRDC include Mannheimia haemolytica and 
Pasteurella multocida. Haemophilus somnus may also be 
involved in cases of pneumonia and can cause severe 
damage to heart muscles. Mycoplasma bovis have the 
potential to further complicate the BRDC pathogenesis 
(Griffin et al., 2010). Many researchers have examined 
the impact of various microbial agents and their 
interaction in the development of the clinical outbreaks of 
BRDC, vaccination trials (Wildman et al., 2008), 
serological (Loneragan et al., 2005), and molecular 
surveys (Thonur et al., 2012; Fratrić et al., 2012). The 
appearance of clinically affected animals does not 
typically differ significantly regardless of the pathogen 
involved. Viral agents may occasionally produce a clinical 
syndrome consistent with BRD without bacterial co-
infection (Decaro et al., 2008). BRDC is one of the most 
costly diseases due to a decline in productivity, higher 
levels of mortality and morbidity (Loneragan et al., 2001; 
Zahur et al., 2007), increased labor costs and reduced 
carcass value (Schneider et al., 2009; Garcia et al., 2010). 
BRDC is the most common cause of mortality in dairy 
cattle, with highest morbidity and higher mortality, which 
are noticed in case of mixed viral and bacterial infections 
(Duff and Galyean, 2007). Diagnosis of BRDC can be 
achieved through routine clinical examination and 
observation, quantified in the form of a clinical score. The 
second diagnostic method is to use a series of laboratory 
tests available to identify microbial agents involved. 
 
Bovine Herpesvirus 1 (BHV-1): BHV-1 has an outer 
layer (peplos) and belongs to the genus of Varicellovirus, 
subfamily of Alphaherpesvirinae, and family of 
Herpesviridae (Šamanc et al., 2009). Strains of BHV-1 
have been classified into five subtypes, according to the 
results of testing their genome: 1, 2a, 2b, 3a and 3b 
(Đurišić et al., 2003). Subtype 1 of BHV-1 was isolated in 
cases of IBR, subtype 2 in genital disease accompanied by 
the appearance of rashes and inflammation of the mucous 
membrane of the vulva and vagina of cows (infective 
pustular vulvovaginitis - IPV), and subtype 3 in cases of 
neuralgic disease (bovine encephalitis herpesvirus - 
BEHV). Balanoposthitis in bulls, abortions and fatal 
multi-systemic infectuous clinical forms in cattle are 
described as a result of BHV-1 infection (Nišavić et al., 
2010; Takiuchi, 2005). Prevalence of BHV-1 is even more 
than 50% in Serbia (Lazić et al., 1995). Lazić et al. (2001) 
investigated the humoral immunological response in 26 
cows vaccinated with anti BHV-1 vaccine ("Borinak", 
Mevak, Nitra, Slovak Republic). Prior to vaccination, the 
values of Ab titers ranged from 1:4 to 1:64. At the time of 
parturition they ranged from 1:64 to 1:1024 in blood sera, 
and from 1:256 to 1:2048 in colostral sera. Specific Ab for 
BHV-1 was determined in 2 calves from these cows 
before feeding with colostrums. After feeding with 
colostrum the highest values for Ab titers were found in 2 
days old calves, while the lowest values were noticed in 
90 days old calves. Lazić et al. (2003) conducted a 
preliminary serological testing of 10 cattle herds and 
found that the infection was caused by BHV-1 was 
present in 8 herds, and the percentage of seropositive 
animals tested ranged from 37 to 98%. Lazić et al. (2004) 
report that an infection caused by a virus PI-3 was present 
in all 10 herds tested, and infections caused by IBRV and 
BVDV in 8 herds. Lazić et al. (2008) examined the 
influence of number of animals per household on 
epizootiology of BHV-1 infection. Households were 
classified according to the number of animals on one 
farm: 6 to 20, 21 to 50 and more than 50 animals in one 
herd. Prevalence of BHV-1 infection was estimated and 
led to a conclusion that the more animals raised in a 
household, the higher the number of cattle infected with 
BHV-1. Turnover of infected breeding animals from large 
herds spread BHV-1 infection to small herds of cattle. 
Šamanc et al. (2009) conducted comparative testing of 92 
samples of blood serum of unvaccinated calves and 
heifers for the presence of Ab against BRSV, PI-3 and 
BHV-1 by indirect enzyme immunoassay (iELISA), 
revealed the presence of Ab against BHV-1 in 19 
(20.65%) of the samples. 
Diagnosis of BHV-1 infection was usually done by 
isolating the virus, detection of viral antigens by using the 
ELISA or immunofluorescence technique. Polymerase 
chain reaction (PCR) is one of the nucleic acid 
hybridization techniques capable to detect DNA of three 
major viral respiratory pathogens of cattle (Thonur et al., 
2012). Nišavić et al. (2010) isolated the BHV-1 from 
bovine nasal and ocular swabs, as well as from lungs, 
trachea and tonsils samples and identified it by virus-
neutralization test (VNT). Further identification was done 
by PCR assay based on two pairs of primers selected from 
the sequence of gB glycoprotein gene which amplified a 
478 bp fragment and thymidine kinase gene which 
amplified an 183bp fragment. Comparative analysis of 
DNA fragments of controlled laboratory strain TN 41 of 
BHV-1 and isolated strains obtained by PCR with primers 
for viral thymidine kinase gene coding region, confirmed 
that the isolated strain belongs to BHV-1. 
 
Bovine Respiratory Syncytial Virus (BRSV): BRSV 
belongs to the genus of the Pneumovirus, subfamily of 
Paramyxovirinae, and the family of Paramixoviridae 
(Šamanc et al., 2009). Quinting et al. (2007) stated that 
the disease usually occurs in cattle younger than 18 
months and calves at the age of 10 days to several months. 
Bugarski et al. (2011) conducted serological examination 
on dairy farms and cattle feedlots in Vojvodina on BRSV 
infection and revealed that they cause 60-70% of 
outbreaks of pneumonia in dairy and beef cattle, with 
different rates of mortality. Determination of the titer of 
Ab against BRSV in the blood sera was performed by 
VNT, using BRSV strain A5198 (ATCC USA). One of 
the dairy farms showed 100% of seropositive animals. 
From a total of 223 tested serum samples from feedlots, 
60.09% contained Ab against BRSV, and seroprevalence 
depending on the phase of fattening. The results of testing 
92 samples of blood serum of cattle in Serbia using 
iELISA confirmed 40 samples of Ab against the BRSV 
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and PI-3 virus (Šamanc et al., 2009). Kurćubić et al. 
(2012) determined genome of the BRSV by Real-time 
RT-PCR in all 20 examined samples of discharge from the 
nasal mucosa of the diseased beef cattle from two 
experimental farms, and confirmed findings of Brodersen 
(2010) and Raaperi et al. (2012), stating that the BRSV is 
a major cause of respiratory diseases and a major 
contributor to the BRDC.  
 
Bovine Viral Diarrhea Virus (BVDV): BVDV belongs 
to the family of Flaviviridae in the genus Pestivirus 
(Wegelt, 2011). Ridpath and Fulton (2009) revealed that 
diversity of BVDV reflected through the 12 BVDV1 
subgenotypes (BVDV1a to BVDV11) and two BVDV2 
subgenotypes (BVDV2a and BVDV2b), hamper the 
production of effective vaccines and could potentially 
complicate the reading of the diagnostic tests results. 
BVDV can be divided into the cytopathogenic (cp) and 
non-cytopathogenic (ncp) biotypes, based on the presence 
or absence of the visible cytopathic effect in infected cell 
cultures. PI virus carriers with a long-term life play the 
key role in BVDV epidemiology. 
 The presence of BVDV infection in Serbia has 
unofficially confirmed earlier (Kurćubić, 1993; Petrović, 
2002; Petrović et al., 2004; Petrović, 2006; Mahmood et 
al., 2012). Kurćubić (1993) conducted study on dairy 
farms where the percentage of BVDV seropositive 
animals varied between 30.55 and 52.24%, depending on 
the age category and herd management. On the second 
farm with beef cattle (aged 6 to 7 months) 55.81% of 
seropositive sera was revealed. Petrović et al. (2004a; 
2004b) detected the ncp BVDV isolates 0016 and 0017 
and the cp isolate Beograd by indirect immunostaining 
methods. Official registration of BVDV infection of cattle 
in Serbia and Montenegro was received from the OIE 
reference laboratory (Veterinary Laboratories Agency, 
Weybridge, UK - letter of December 9, 2002). Direct 
sequencing of PCR products, alignment and phylogenetic 
analysis showed that the 0016 and Beograd isolates were 
of genetic subtype BVDV-1f (first report of a cp BVDV 
belonging to the 1f subgroup), whilst the 0017 isolate 
belonged to subtype 1b. Petrović (2006) examined 12083 
blood samples of cattle older than 6 and the presence of 
specific Ab against BVDV was established in 4647 
(38.46%) of the tested animals. 
 Ahmad et al. (2012) confirmed that both the serum 
and ear notch biopsy can be used for the detection of PI 
and genotyping of prevailing BVDV, but ear notch 
biopsies had less sensitivity (P<0.05) for the detection of 
acute transiently infected cattle than serum samples. 
 Basic approach in BVDV infections control is 
vaccination (Raue et al., 2011; Luo et al., 2012) and 
another approach is identification of PI cattle and their 
removal from the herd, without vaccination. Kurćubić et 
al. (2009) made fisrst attempt on identification of cattle PI 
with the BVDV among the dairy cattle that were 
seronegative in both examination of paired sera (first and 
28. days), allow the ELISA testing to determine the 
BVDV antigens (Ag) in serum. BVDV Ag was not 
confirmed in either case. In the same manner, Kurćubić et 
al. (2010a) tried to identify the presence of PI in cattle of 
various ages from herds with a different production 
purpose (fattening/milk) and BVDV Ag was not 
confirmed in either of the cases. The explanation for the 
lack of experimental proof of the presence of PI cattle can 
be found in the fact that the not tested sera of all animals 
from the farms on presence of BVDV Ag, whose age 
allowed this examination, as well-known fact that the 
prevalence of PI cattle was extremely low (0.75-2%). 
Kurćubić et al. (2010b) used VNT to examine blood sera 
collected from sheep of different age categories reared 
under different systems for the presence of BVDV and 
Border disease virus (BDV) infections in attempt to 
clarify the potential for transmission to cattle and vice 
versa. From animals breed on five mini farms that were 
not exist cohabitation between small and big ruminants in 
the same facilities and 5 sheep farms whose owners also 
raised cattle. Samples of blood were taken from 5 young 
sheep aged up to 12 months and 5 from the older sheep 
per farm. Serological examinations did not detect the 
presence of anti-BVDV specific Ab to BVDV-1 and 
BVDV-2 genotypes in any of the 100 tested blood serum 
samples, like anti-BDV Ab to BDV Moredun strain.  
 
Parainfluenza Type-3 Virus (PI-3V): PI-3V is an 
immunosuppressive RNA virus belonging to the 
Paramyxoviridae family. PI-3V is usually transmitted in 
nasal discharge, favored by close contact, insufficient 
ventilation in facilities and stale air during shipping of 
cattle. The PI-3V was detected in acute and chronicle 
cases of pneumonia predominantly in young cattle during 
fall and winter. PI-3V often takes part in mixed infections 
with BHV-1 and BVDV, with severe clinical signs and 
fatal outcome. Fever, cough, mucous yellow nasal and eye 
discharge were noticed during the mild course of the 
disease. Milić et al. (2003) committed biochemical 
characterization of the surface glycoprotein Ag of purified 
PI-3V virions with molecular weights of 112 kD, 81-82 
kD and 30-31 kD (HN and F Ag). After that, the 
activation of PI-3V followed with trypsin-versen 
representing a prerequisite for the application of the cell 
fusion test, hemolytic test and the test of inhibition of cell 
fusion with hyper immune sera against PI-3V can be used 
for fast detection and identification of fusion and hem 
agglutinin-neuraminidase PI-3V Ag. Lazić et al. (2009) 
indicate that in Serbian literature there are only few data 
on PI-3V as the causative agent of BRDC, especially in 
beef cattle. Serological surveys of PI-3V infection are 
strongly recommended. His research presented the BRDC 
outbreak accompanied by PI-3V infection in one bull 
calves fattening unit of industrial type. The geometric 
mean value of Ab titer against PI-3V was 14.58 at the 
moment of disease, while 3 and 6 weeks after outbreak it 
was 45.25 and 54.44, and at the end of fattening it was 
22.11. Šamanc et al. (2009) state that the results of testing 
of 92 blood serum samples of cattle using iELISA 
confirmed the presence of Ab against PI-3V in 77 of 
samples (83.69%).  
 
Bacterial agents: The most common bacteria found in the 
lungs of cattle with BRDC are Mannheimia haemolytica 
and Pasteurella multocida. Fulton (2009) states in his 
review that  sixteen different serotypes of biotype A and T 
of Mannheimia haemolytica were classified, with twelve 
different serotypes based on capsular serotypes for the A 
serotype. High immunogenic potential for incorporation in  
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Fig. 1: Prominent fibrinous pleuritis and pleural effusion. The pulmonary 
interlobular septa are distended by yellow gellatinous edema and fibrin. 
(Courtesy: Nikola Vaskovic, Veterinary Specialized Institute, Kraljevo, 
Serbia). 
 
P. multocida vaccine have leucotoxin produced by 
recombinant DNA technology and outer membrane 
protein PlpE. Today's researchers opinions based on the 
experimental evidence that the P. multocida is primary 
pathogen in the lungs of cattle have been confirmed in 
five-years research of Kurćubić et al. (2000). They 
examined a total of 1435 nasal swabs originating from 
diseased beef cattle with the symptoms that indicate 
BRDC. The most commonly isolated are Pasteurella 
multocida and Pasteurella haemolytica (62.78 and 
40.20%), as well as Corynebacterium pyogenes (53.44%), 
Staphylococcus albus (24.87%) and Streptococcus 
viridans (14.07%). Hellenbrand et al. (2012) report that 
Histophilus somni is a Gram-negative pleomorphic 
coccobacillus that causes respiratory, reproductive, 
cardiac and neuronal diseases in cattle. Recently, it was 
discovered that bovine neutrophils and macrophages 
produce extracellular traps in response to Mannheimia 
haemolytica, which suggest that extracellular traps may 
play a role in the host response to H. somni infection in 
cattle. Mycoplasma bovis is a bacterial pathogen causing 
respiratory disease, otitis media, poly-arthritis, mastitis, 
and a variety of other diseases in dairy and beef cattle, 
with an important impact on the health, welfare, and 
productivity. Difficulties in implementation of M. bovis 
diagnostic and control procedures originate from very 
different manifestation of the disease, response to 
vaccination and medication, and lacks in knowledge about 
these diseases (Maunsell et al., 2011).  
 
Pathology: The gross lesions in the case of pneumonic 
Mannheimiosis are characterized by fibrinous 
bronchopneumonia, with prominent fibrinous pleuritis and 
pleural effusion. The interlobular septa is distended by 
yellow, gellatinous edema and fibrin (Fig. 1). Coagulation 
necrosis interlobular interstitial oedema and congestion 
are present as well. Microscopically first neutrophils fill 
the bronchial, bronchiolar and alveolar spaces, and then 
alveolar macrophages start to appear in the lungs (Fig. 2). 
Lung lessions caused by viruses in acute phases are those 
of bronchointestitial pneumonia in almost all the animal 
species (Fig. 3) (Marinković et al., 2007). 
Microscopically, the lesions are in range of necrotizing 
bronchiolitis, necrosis of type I pneumocytes with 
hyperplasia  of  type II  pneumocytes, and mild interstitial  
 
 
Fig. 2: Microscopically neutrophils fill the bronchial, bronchiolar and alveolar 
spaces, alveolar macrophages start to appear in the lungs, H&E, 200 ×. 
(Courtesy: Natalija Fratric and Sanja Aleksic-Kovacevic, University of 
Belgrade, Serbia). 
 
 
 
Fig. 3: The lesions are composed of necrosis of type I pneumocytes with 
hyperplasia of type II pneumocytes, and interstitial edema, H&E, 400 ×. 
(Courtesy: Natalija Fratric and Sanja Aleksic-Kovacevic, University of 
Belgrade, Serbia). 
 
 
 
Fig. 4: The mycoplasmal also cause Bronchiolitis and prominent 
interstitial reaction. Numerous mononuclear inflammatory cells are 
present. H&E, 200 ×. (Courtesy: Natalija Fratric and Sanja Aleksic-
Kovacevic, University of Belgrade, Serbia). 
 
and alveolar edema. The mycoplasmal also cause 
bronchiolitis, bronchiolar and alveolar necrosis, and 
interstitial reaction (Fig. 4). A mixture of desquamated 
epithelial cells, macrophages, and mononuclear cells are 
usually present in the lumen of bronchioles and alveoli.  
 
Vaccines and Vaccination Programmes: Significant 
achievements in vaccinology in the last 40 years have not 
yet enabled production of an ideal vaccine, which is 
expected to be multivalent, to create a protective immune 
response in neonatal calves regardless of the presence of 
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colostral antibodies, ensure long immune protection after 
the single vaccination, not to cause local and/or systemic 
reactions, and not to be applied by the syringe and 
injection needle (Rogan, 2010). Researchers have studied 
the impact of lincenced and experimental vaccines on 
morbidity, mortality, and other control measures in cattle 
(Larson and Step, 2012). Kurćubić et al. (2011a) evaluate 
the immunogenicity of two experimentally prepared 
inactivated vaccines (mono and polyvalent) containing 
BVDV reference and field strains. Three experimental 
groups were formed: 10 calves vaccinated twice (days 1 
and 28) s.c. with 2 mL of inactivated polyvalent vaccine 
per animal (Group I); 10 calves vaccinated in same 
manner with inactivated monovalent vaccine (Group II) 
and 9 unvaccinated calves (Control, Group C). Blood sera 
were obtained from the immunized animals by standard 
procedure: on days 0, 14, 28, 42 and 56 post 
immunization, and  tested by VNT. The immune response 
developed more rapidly and values of geometric mean 
titer (GMT) for BVDV neutralizing Ab were substantially 
higher in blood sera of calves from Group II. In the 
second part of the study (Kurćubić et al., 2011b), the 
immune response to same BVDV vaccine was evaluated 
by the iELISA method. The occurrence of a specific Ab 
against BVDV was first detected on day 42 post 
immunization in both experimental groups of beef calves 
and remained steady until day 56. The statistically very 
significant differences (at the 99 % level) observed 
between the test animals of groups I and II on days 42 and 
56 after vaccination suggest considerably higher 
immunogenicity of the monovalent vaccine. Đurišić et al. 
(2003) report that large pharmaceutical companies 
developed a vaccine manufacturing technology in which 
the viral genome is partially shortened or part of the 
genome is cut and incorporated into the genome of other 
living systems such as cell cultures to produce precisely 
defined glycoprotein (marker vaccines) which allows the 
identification of vaccinated and infected animals. There 
are two vaccines for active immunization of healthy cattle 
and calves against respiratory disease currently available 
in Serbia, produced by the only domestic manufacturer. 
Vibak® is combined, polyvalent vaccine (ATCvet code 
QI02AF) containing live attenuated viruses (IBRV and PI-
3V) and cell culture of bacteria Diplococcus pneumoniae, 
Pasteurella multocida and Corynebacterium pyogenes. 
The other is inactivated oil vaccine Respi-Ol® (ATCvet 
QI02AD06), containing the immunogenic strains of PI-3V 
and IBRV. The only available registered import vaccine is 
Bovilis® IBR marker inac (Intervet International B.V., 
ATCvet QI02AA03), which contains inactivated BHV-1 
strain GK/D.  
 
Medication: The therapeutic approach for BRDC 
includes antimicrobial treatment due to the frequent 
participation of bacteria. The data concerning the use of 
ancillary medications (nonsteroidal anti-inflammatory 
drugs, immunomodulators, bronchodilators) are often 
based on experimental models of BRDC (Francoz et al., 
2012). Spreading of infective bacterial agents which infect 
the cattle with BRDC can be prevented by the use of 
antimicrobial agents when the number of “high risk” 
calves reach the "tolerance level". Drugs for metaphylaxis 
(mass medication) were selected on the basis of 
susceptibility testing, mainly with prolonged action, for 
the treatment of animals who were suspected of BRDC 
which have been in contact with the infected cattle and 
gave good results in reducing morbidity (Edwards, 2010; 
Urban-Chmiel and Grooms, 2012). The new macrolide 
antibiotics, third generation cephalosporins, fluoro- 
quinolones and fenicols showed high clinical success (70-
90%) in the treatment of cattle suffering of BRDC caused 
by Pasteurella’s, 1-2 days after treatment. Tulatromycin, 
florfenicol, ceftiofur are much more effective against most 
Pasteurella strains that are resistant to other antimicrobial 
drugs. Its liposolubility allowed a quick and complete 
absorption in the lung parenchyma, held there for seven 
days at concentrations higher than the minimal inhibitory 
concentration (MIC) for most bacteria and mycoplasma. 
Jezdimirović et al. (2011) examined the clinical efficacy 
of tulathromycin (TU) and florfenicol (FL) in the 
treatment of bronchopneumonia (BP) caused by 
Pasteurella multocida isolated from diseased six months 
old Holstein calves. TU proved to be a drug of first choice 
in the treatment of BP caused by P. multocida. Recent 
findings of Kurćubić et al. (2012) revealed that the most 
common bacteria in fattening cattle suffering from BRDC 
were P. multocida, Aeromonas viridans and 
Corynebacterium bovis, suggesting their higher 
importance in BRDC in Serbian beef cattle in regard to 
Mannheimia haemolytica, predominantly determined 
worldwide. Susceptibility testing revealed that the most 
efficient antibiotics against P. multocida isolates were 
enrofloxacin and florfenicol (100% of examined isolates 
sensitive on both antibiotics). Portis et al. (2012) tested 
bovine isolates of Mannheimia haemolytica, Pasteurella 
multocida, and Histophilus somni, collected over the last 
ten years to examine the in vitro sensitivity of the 
commonly applied ad us vet antibiotics that are available 
in the market. Ceftiofur remained very active against all 
isolates. Penicillin retained good activity against P. 
multocida and H. somni isolates. Enrofloxacin MIC50 
values for the 3 pathogens also did not change over time, 
unlike the MIC90 values, which increased by at least 4-
doubling dilutions. Ninety percent or more of M. 
haemolytica and H. somni isolates were susceptible to 
florfenicol, while susceptibility among P. multocida was 
79% or higher. All 3 organisms showed declines in 
tilmicosin and tulathromycin MIC50 and MIC90 values.  
 
Guidelines for Future Research: One of the most 
important tasks for the researchers to determine now is the 
trend of resistance of isolated bacteria to antibiotics used 
in clinical veterinary practice. If they detect multiresistant 
pathogens listed diseases, with sampling performed from 
healthy individuals who were not under antibiotic 
treatment, with the aim to isolate non-pathogenic strains 
sensitive to all antibiotics, which could be embedded in a 
new experimental vaccines. It is essential that a detailed 
analysis of selected characteristic sequences determine the 
position of the bacteria and viruses that lead to BRDC in 
the phylogenetic tree in relation to the same strains in the 
environment and then form a database. Phylogenetic 
analysis based on the comparison of the nucleotide/amino 
acid sequences of specific genetic determinants are an 
extremely powerful tool in modern approach in 
epizootiology, in order to determine the genetic diversity, 
Pak Vet J, 2014, 34(1): 11-17. 
 
16
assess the evolutionary flow, a retrospective analysis of 
the geographical distribution of different antigenic types 
and subtypes of analyzed microbial agents was carried 
out. Vaccines and diagnostic manufacturers are interested 
in the results of these studies. Improvement of the existing 
or development of new vaccines can incorporate native 
and current determined viral and bacterial specific 
antigens, which are described and standardized by 
molecular methods.  
 
Conclusion: Contemporary approach for BRDC 
researchers and veterinary clinicians in Serbia is to enable 
faster and more accurate (field) diagnosis in order to get a 
better prevention of the disease and achieve a significant 
reduction in economic losses. The ultimate goal is to 
improve the beef meat production intended for human 
consumption. It is necessary to study in detail a large 
number of predisposing environmental factors and 
applications of obtained results in adjustment of the herd 
management, taking into account the principles of animal 
welfare. It is imperative to properly design vaccination 
programs and reduce the usage of antibiotics, especially 
the drugs used routinely in human medicine.  
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